SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-000090
Filing Date
2023-01-06
Accepted
2023-01-06 16:04:12
Documents
4
Period of Report
2023-02-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230208xdef14a.htm DEF 14A 259724
2 GRAPHIC tmb-20230208xdef14a006.jpg GRAPHIC 180524
3 GRAPHIC tmb-20230208xdef14a001.jpg GRAPHIC 6394
4 GRAPHIC tmb-20230208xdef14a005.jpg GRAPHIC 140875
  Complete submission text file 0001558370-23-000090.txt   712904
Mailing Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE B-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14778 | Film No.: 23515069
SIC: 2834 Pharmaceutical Preparations